Depression: open trials in Slovakia

5 open trials have a site in Slovakia. Registry data; only the trial team decides who can take part.

NCT06559306
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Centrum Zdravia R.B.K. s.r.o., Bardejov · Univerzitna nemocnica L. Pasteura Kosice, Košice · Liptovska Nemocnica S Poliklinikou Mudr. Ivana Stodolu Liptovsky Mikulas, Liptovský Mikuláš · PsychoLine s.r.o., Rimavska Sobota · Mentum s.r.o., Stare Mesto · Crystal Comfort S.R.O., Vranov nad Topľou
Registry updated 2026-11-03
NCT06966401
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Trial Treatment · Phase 3 · Neurocrine Biosciences
Dana Ignjatovićová, spol. s r.o, Banská Bystrica · Centrum Zdravia R.B.K. s.r.o., Bardejov · Nemocnica s poliklinikou Prievidza so sidlom v Bojniciach, Bojnice · Epamed s.r.o., Kosice - Zapad · PsychoLine s.r.o., Rimavska Sobota · Mentum s.r.o., Stare Mesto · Crystal Comfort S.R.O., Vranov nad Topľou
Registry updated 2026-11-02
NCT07065240
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
Trial Treatment · Phase 2 · Seaport Therapeutics
PsychoLine s.r.o., Rimavska Sobota · Mentum s.r.o., Stare Mesto · Crystal Comfort S.R.O., Vranov nad Topľou
Registry updated 2026-10-06
NCT07161700
An Open-Label Extension Study to Evaluate the Safety and Tolerability of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 OLE Study)
Trial Treatment · Phase 2 · Seaport Therapeutics
MENTUM s.r.o., Bratislava · PsychoLine s.r.o., Rimavska Sobota · Crystal Comfort S.R.O., Vranov nad Topľou
Registry updated 2026-10-06
NCT06911112
NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Trial Treatment · Phase 3 · Neurocrine Biosciences
Dana Ignjatovićová, spol. s r.o, Banská Bystrica · Centrum Zdravia R.B.K. s.r.o., Bardejov · Nemocnica s poliklinikou Prievidza so sidlom v Bojniciach, Bojnice · Epamed s.r.o., Kosice - Zapad · PsychoLine s.r.o., Rimavska Sobota · Mentum s.r.o., Stare Mesto · Crystal Comfort S.R.O., Vranov nad Topľou
Registry updated 2026-08-11

All Depression trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error

Depression: open trials in Slovakia

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)

An Open-Label Extension Study to Evaluate the Safety and Tolerability of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 OLE Study)

NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)